Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes? #MMPMID33248018
Donath MY
Cell Metab 2021[Jan]; 33 (1): 2-4 PMID33248018show ga
Patients with a metabolic syndrome (overweight, diabetes, hypertension, and dyslipidemia) have a particularly bad outcome if infected with SARS-CoV-2. Yu et al. (2020) suggest that insulin therapy itself may promote fatality in patients with COVID-19 and diabetes.
|COVID-19 Drug Treatment[MESH]
|COVID-19/complications/*metabolism[MESH]
|Diabetes Mellitus, Type 2/complications/drug therapy/*metabolism[MESH]